Guided Therapeutics (GTHP) EBITDA Margin (2011 - 2025)
Guided Therapeutics' EBITDA Margin came in at -119.83% for Q4 2025, up 53080.17 percentage points from -53200.00% a year earlier and up 685.17 percentage points from the prior quarter.
Powered by 
Analysis
Guided Therapeutics (GTHP) EBITDA Margin (2011 - 2025) Analysis & Trends
For FY2025, Guided Therapeutics' EBITDA Margin was -307.95%, up 29677.76 percentage points from FY2024.
- EBITDA Margin carries a five-year change of +623.42 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was -29985.71% in FY2024 (-26467.35 pp), -3518.37% in FY2023 (+22089.32 pp), -25607.69% in FY2022 (-22702.75 pp) and -2904.94% in FY2021 (-1973.57 pp).
- The Q4 2025 figure represents the highest quarterly EBITDA Margin since Q4 2012.
- The fastest year-over-year change in EBITDA Margin over five years came in Q4 2025 (a gain of 53080.17 percentage points), and the weakest in Q4 2024 (a drop of 51690.63 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 251.30 Bn | 230.45 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 174.70 Bn | 145.78 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 158.94 Bn | 142.76 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 145.87 Bn | 125.42 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 111.49 Bn | 77.36 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 106.96 Bn | 93.08 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 63.62 Bn | 58.63 Bn | 3.85 Bn | 28.17% |
| 8 | Edwards Lifesciences | 50.80 Bn | 34.92 Bn | 1.35 Bn | 31.93% |
| 9 | Becton Dickinson | 49.59 Bn | 46.74 Bn | 2.32 Bn | 24.62% |
| 10 | Guided Therapeutics | 19.31 Mn | 18.78 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -119.83% |
| Sep 30, 2025 | -805.00% |
| Jun 30, 2025 | -649.57% |
| Dec 31, 2024 | -53,200.00% |
| Mar 31, 2024 | -5,950.00% |
| Dec 31, 2023 | -1,509.38% |
| Jun 30, 2023 | -3,413.64% |
| Mar 31, 2023 | -3,822.73% |
| Sep 30, 2022 | -40,766.67% |
| Jun 30, 2022 | -14,340.00% |
| Mar 31, 2022 | -8,860.00% |
| Dec 31, 2021 | -881.67% |
| Sep 30, 2021 | -2,063.16% |
| Jun 30, 2021 | -28,050.00% |
| Dec 31, 2020 | -1,056.00% |
| Sep 30, 2020 | -166.23% |
| Dec 31, 2019 | -912.50% |
| Sep 30, 2019 | -16,900.00% |
| Jun 30, 2019 | -29,400.00% |
| Mar 31, 2019 | -1,194.44% |
API Access
Guided Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=GTHP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "GTHP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=GTHP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();